Back to Global NewsPublished: 9 Feb 2026Download AppJoin TelegramWhy Novo Nordisk’s Lawsuit Against Hims & Hers Could Redefine the Weight‑Loss Drug Market#Novo Nordisk#Hims & Hers#Obesity Drugs#Pharma Litigation#Healthcare InvestingDownload AppJoin CommunityShare Article